NightHawk Biosciences, a contract development and manufacturing organization (CDMO), reported that its BioManufacturing subsidiary Scorpius has completed a demonstration run in the company’s process development lab for a microbial vaccine program developed by a research university that is NIH and DTRA (Defense Threat Reduction Agency) funded. Jeff Wolf, CEO of NightHawk, said, “This first phase of a multi-million-dollar project was particularly noteworthy, as we achieved a successful demonstr...